San Francisco, California - March 18th, 2025 - VeriSIM Life is proud to announce that their CEO, Dr. Varshney, has been named a finalist for the 'Executive Leader Award - Woman Executive of the Year' in the Women in AI Awards North America 2025. This prestigious award recognizes outstanding leadership and significant contributions to the field of artificial intelligence.
The Women in AI Awards North America 2025, set to take place on June 6, 2025, in Toronto, Canada, celebrates the achievements of women and allies in AI. The event recognizes excellence across various categories, including trailblazers, executive leaders, industry innovators, startup entrepreneurs, researchers, rising stars, champions of DEI, and leaders in responsible AI.
Dr. Varshney's nomination is a testament to her visionary leadership and dedication to advancing explainable approaches to AI technologies that drive meaningful change. Under her guidance, VeriSIM Life has become a leader in the development of AI-enabled solutions for healthcare, contributing to the ability to get treatments to patients faster and more efficiently.
"I am deeply honored to be recognized as a finalist for the 'Woman in AI of the Year' award at the Women in AI Awards North America 2025. At VeriSIM Life, we are revolutionizing drug development by leveraging cutting-edge AI technologies to accelerate the discovery and delivery of life-changing therapies. This recognition is a testament to the hard work and dedication of our entire team, and we are committed to continuing our mission to transform healthcare through innovation,” says Dr. Varshney.
VeriSIM Life is honored to have Dr. Varshney represent the company on this prestigious list of finalists, which includes other remarkable women such as Briana Brownell, Founder and CEO of Pure Strategy Consulting Inc. (Canada); Chathuri Daluwatte, Head of AI Diagnostics at Alexion AstraZeneca Rare Disease (United States); and Claudia Del Pozo, Founder and Executive Director of Eon Institute (Mexico). The winners will be announced at the formal event in June
About Women in AI
Women in AI (WAI) is a global network of female experts and professionals in the field of Artificial Intelligence working towards inclusive AI that benefits a global society. Through empowerment, knowledge and active collaboration, WAI has grown into a recognized global platform of 16000+ members across 150+ countries with over 400 volunteers and led by prominent and influential women in Artificial Intelligence.
About VeriSIM Life
VeriSIM Life has developed a sophisticated computational platform that leverages advanced AI and ML techniques to improve drug discovery and development by significantly reducing the time and money it takes to bring a drug to market. BIOiSIM® is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. The platform predicts the likelihood of a candidate's success in clinical trials early in the preclinical stage, while reducing unnecessary experimentation and better informing key program decisions. For more information, visit www.verisimlife.com.
.png)
